In a research report published Monday, Chardan Capital analyst James McIlree downgraded shares of Globalstar, Inc. (NYSEMKT:GSAT) from Buy to Neutral, citing increased risks of ultimate …
Chardan Capital analysts are weighing in today on satellite company Globalstar, Inc. (NYSEMKT:GSAT) and drug maker Lion Biotechnologies Inc (NASDAQ:LBIO), as both stocks turned extremely volatile on the …
